ArticleFrontiers in artificial intelligence2026
Study of a Kawasaki disease diagnostic prediction model based on the LightGBM machine learning algorithm.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early Prediction of Non-recovery in Drug-induced Liver Injury by Integrating Genetic Variants and Clinical Variables: An Interpretable Machine Learning Approach.Journal of clinical and translational hepatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kawasaki disease (KD) is an acute systemic vasculitis predominantly affecting children under 5 years of age. Its pathogenesis remains incompletely understood, and the lack of specific diagnostic biomarkers during the acute phase poses substantial challenges to clinical diagnosis. Such diagnostic uncertainty often results in missed or delayed cases, leading to lost therapeutic opportunities and the subsequent development of coronary artery lesions (CAL). The present study aimed to establish a machine learning-based diagnostic model to optimize the KD diagnostic workflow, enable early identification, and reduce the incidence of CAL. Methods: We retrospectively analyzed Pre-treatment clinical data from 4,469 patients admitted to Kunming Children's Hospital between January 2017 and December 2023, including 2,345 patients diagnosed with Kawasaki disease (case group) and 2,124 febrile non-KD patients (control group). A Light Gradient Boosting Machine (LightGBM) algorithm was employed to develop a diagnostic model for KD. Model performance was assessed using the area under the receiver operating characteristic curve (AUC), as well as accuracy, sensitivity, and specificity calculated from the confusion matrix at a classification threshold of 0.5. SHapley Additive exPlanations (SHAP) analysis was performed to identify key predictive features and interpret the model's decision-making mechanism. On the basis of SHAP-derived feature importance and clinical availability, six core variables were selected to establish a simplified diagnostic model, which was further deployed as an offline application. Results: The full-feature LightGBM model achieved an outstanding area under the receiver operating characteristic curve (AUC) of 0.9956. At a classification threshold of 0.5, the confusion matrix yielded an accuracy of 0.9653, a sensitivity of 0.9596, and a specificity of 0.9717. SHAP analysis revealed that C-reactive protein (CRP), activated partial thromboplastin time (APTT), total calcium (Ca Conclusion: Machine learning approaches enable effective simplification of the diagnostic process for KD. The predictive model constructed on the basis of WBC, PLT, CRP, APTT, TT, and ALB shows high diagnostic efficacy and favorable clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.